Literature DB >> 19439404

Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.

Jan K Jensen1, Klavs Dolmer, Peter G W Gettins.   

Abstract

The low density lipoprotein receptor-related protein (LRP) is the principal clearance receptor for serpins and serpin-proteinase complexes. The ligand binding regions of LRP consist of clusters of cysteine-rich approximately 40-residue complement-like repeats (CR), with cluster II being the principal ligand-binding region. To better understand the specificity of binding at different sites within the cluster and the ability of LRP to discriminate in vivo between uncomplexed and proteinase-complexed serpins, we have systematically examined the affinities of plasminogen activator inhibitor-1 (PAI-1) and proteinase nexin-1 (PN-1) in their native, cleaved, and proteinase-complexed states to (CR)(2) and (CR)(3) fragments of LRP cluster II. A consistent blue shift of the CR domain tryptophan fluorescence suggested a common mode of serpin binding, involving lysines on the serpin engaging the acidic region around the calcium binding site of the CR domain. High affinity binding of non-proteinase-complexed PAI-1 and PN-1 occurred to all fragments containing three CR domains (3-59 nm) and most that contain only two CR domains, although binding energies to different (CR)(3) fragments differed by up to 18% for PAI-1 and 9% for PN-1. No detectable difference in affinity was seen between native and cleaved serpin. However, the presence of proteinase in complex with the serpin enhanced affinity modestly and presumably nonspecifically. This may be sufficient to give preferential binding of such complexes in vivo at the relevant physiological concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439404      PMCID: PMC2709341          DOI: 10.1074/jbc.M109.009530

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Structure of the LDL receptor extracellular domain at endosomal pH.

Authors:  Gabby Rudenko; Lisa Henry; Keith Henderson; Konstantin Ichtchenko; Michael S Brown; Joseph L Goldstein; Johann Deisenhofer
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

2.  The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes.

Authors:  G Joslin; R J Fallon; J Bullock; S P Adams; D H Perlmutter
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Molar antithrombin concentration in normal human plasma.

Authors:  J Conard; F Brosstad; M Lie Larsen; M Samama; U Abildgaard
Journal:  Haemostasis       Date:  1983

4.  Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.

Authors:  A E Mast; J J Enghild; S V Pizzo; G Salvesen
Journal:  Biochemistry       Date:  1991-02-12       Impact factor: 3.162

5.  alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition.

Authors:  József Dobó; Peter G W Gettins
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

6.  Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.

Authors:  K Leiper; A Croll; N A Booth; N R Moore; T Sinclair; B Bennett
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

7.  Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

Authors:  B J de Smet; J P de Boer; J Agterberg; G Rigter; W K Bleeker; C E Hack
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

8.  Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.

Authors:  D A Lawrence; S T Olson; S Palaniappan; D Ginsburg
Journal:  Biochemistry       Date:  1994-03-29       Impact factor: 3.162

9.  Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.

Authors:  A Lalazar; K H Weisgraber; S C Rall; H Giladi; T L Innerarity; A Z Levanon; J K Boyles; B Amit; M Gorecki; R W Mahley
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

10.  A glia-derived neurite-promoting factor with protease inhibitory activity.

Authors:  J Guenther; H Nick; D Monard
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  11 in total

1.  Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues.

Authors:  Maartje van den Biggelaar; Jesper J Madsen; Johan H Faber; Marleen G Zuurveld; Carmen van der Zwaan; Ole H Olsen; Henning R Stennicke; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2015-04-21       Impact factor: 5.157

Review 2.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

3.  Quantitative dissection of the binding contributions of ligand lysines of the receptor-associated protein (RAP) to the low density lipoprotein receptor-related protein (LRP1).

Authors:  Klavs Dolmer; Andres Campos; Peter G W Gettins
Journal:  J Biol Chem       Date:  2013-06-23       Impact factor: 5.157

Review 4.  Proteases as therapeutics.

Authors:  Charles S Craik; Michael J Page; Edwin L Madison
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

5.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

6.  High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207.

Authors:  Mary Migliorini; Shih-Hon Li; Anqi Zhou; Cory D Emal; Daniel A Lawrence; Dudley K Strickland
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

7.  Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.

Authors:  Alexey Kolyada; Andrew Porter; Natalia Beglova
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

8.  The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.

Authors:  Peter G W Gettins; Klavs Dolmer
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

9.  A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low-density lipoprotein receptor-related protein).

Authors:  Peter G W Gettins; Klavs Dolmer
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

10.  Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.

Authors:  Christine M Doherty; Robert Visse; Deendayal Dinakarpandian; Dudley K Strickland; Hideaki Nagase; Linda Troeberg
Journal:  J Biol Chem       Date:  2016-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.